Male breast cancer - A prospective registry study the University Women's Hospital Magdeburg in cooperation with the GBG (German Breast Group) the diagnosis and treatment of breast cancer ma

Recruiting

• Conditions: C50.9; Breast, unspecified

• Registration Number: DRKS00009536
• Lead Sponsor: niversitätsfrauenklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 1000

Inclusion Criteria

Patient with histologically confirmed, primary breast cancer
- Written consent of the patient for data collection and for the histopathological provisions on tumor tissue.
- Inclusion of patients can only up to the beginning of chemotherapy
- If no chemotherapy must be given, inclusion within 6 months is possible after surgery

Exclusion Criteria

no

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
> Prospective recognition of the primary cases of breast cancer in men with the determination of recurrence-free survival

Secondary Outcome Measures

Name	Time	Method
> Determination of overall survival<br>> Stage and biological characteristics of breast cancer<br>> Validation of therapeutic modalities (medications, CHT, Op-type radiation)<br>> Sensitivity of diagnosis (clinical examination, ultrasound, mammography)<br>> Determining histopathological factors on tumor tissue